Agenus, Inc. (NASDAQ:AGEN) Q2 2019 Earnings Conference Call August 8, 2019 8:30 AM ET Company Participants Jennifer Buell – Chief Operating Officer Garo Armen – Chairman and Chief Executive Officer Paisley Myers – Senior Scientist Christine Klaskin – Vice President-Finance Conference Call Participants Harshita Polishetty – B. Riley FBR Rob Andrew – William Blair Brian Visneski – Private Investor Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Agenus Second Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☒ Title of each class Trading symbol(s) Name of each exchange on which registered Common stock, par value $0.01 AGEN The Nasdaq Capital Market Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) ...

Agenus, Inc. (NASDAQ:AGEN) Q1 2019 Earnings Conference Call May 9, 2019 8:30 AM ET Company Participants Jennifer Buell – Chief Operating Officer Garo Armen – Chairman and Chief Executive Officer Dhan Chand – Senior Scientist Bruno Lucidi – Chief Executive Officer-AgenTus, Cell Therapy Business Entity Christine Klaskin – Vice President of Finance Conference Call Participants Harshita Polishetty – B. Riley FBR Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Agenus Fi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of (I.R.S. Employer i ...

Agenus Inc. (NASDAQ:AGEN) Q4 2018 Results Earnings Conference Call March 14, 2019 8:30 AM ET Company Participants Jennifer Buell - Chief Operating Officer Garo Armen - Chairman and Chief Executive Officer Anna Wijatyk - Vice President of Clinical Development Christine Klaskin - Vice President of Finance & Principal Accounting Officer Conference Call Participants Matt Phipps - William Blair Operator Good morning ladies and gentlemen. Thank you for standing by and welcome to the Agenus Fourth Quarter 2018 Con ...